Management of Chronic Graft-versus-Host Disease (cGvHD)

home / expert-perspective-tumor-board / management-of-chronic-graft-versus-host-disease-cgvhd

Expert perspectives on the management of chronic graft-versus-host disease (cGvHD) from virtual tumor board discussions. The segments cover treatment approaches, supportive care strategies, and clinical trial data on agents like ibrutinib, ruxolitinib, and belumosudil for optimizing care in cGvHD. The discussions also evaluate the management of a severe multi-organ cGvHD case, covering diagnosis, emerging therapies, and supportive interventions, featuring insights from Dr. Catherine Lee, Dr. Yi-Bin Chen, and Karolina Faysman, NP.